- Reporting Forms
- Webinars
- Guidance
IDOH Resources
IDOH TB Disease Treatment and Management Card (pdf)
IDOH Latent TB Infection Screening and Treatment Card (pdf)
TB Disease
CDC Treatment for TB Disease Webpage
Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children, ATS/IDSA/CDC
Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis, ATS/ISSA/CDC
Interim Guidance: 4-Month Rifapentine-Moxifloxacin Regimen for the Treatment of Drug-Susceptible Pulmonary Tuberculosis — United States, 2022
Latent TB Infection (LTBI)
Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020Additional Resources
Global TB Institute at Rutgers LTBI Videos for Primary Care Providers
Page last reviewed/updated: April 2026
